• Users Online: 67
  • Print this page
  • Email this page
ORIGINAL RESEARCH ARTICLE
Year : 2016  |  Volume : 9  |  Issue : 1  |  Page : 75-84

Allele and genotype frequencies of the two single nucleotide polymorphisms in the VKORC1 gene that are most important for warfarin treatment among Emiratis


1 Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; United Nations University – Maastricht Economic and Social Research Institute on Innovation and Technology (UNU-MERIT), Faculty of Humanities and Sciences, University of Maastricht, Maastricht, The Netherlands
2 Department of Pathology, College of Medicine and Health Sciences, University, Al Ain, United Arab Emirates
3 Department of Paediatrics, College of Medicine and Health Sciences, University, Al Ain, United Arab Emirates
4 Anticoagulation Clinic, Pharmacy Department, Tawam Hospital, Al Ain, United Arab Emirates
5 Institute of Public Health, College of Medicine and Health Sciences, University, Al Ain, United Arab Emirates
6 Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece
7 United Nations University – Maastricht Economic and Social Research Institute on Innovation and Technology (UNU-MERIT), Faculty of Humanities and Sciences, University of Maastricht, Maastricht, The Netherlands

Correspondence Address:
Bassam R Ali
Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain
United Arab Emirates
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.7707/hmj.463

Rights and Permissions

Warfarin is the most widely prescribed anticoagulant worldwide. However, warfarin doses vary up to 20-fold and side-effects (at high doses) or therapy failure (at lower doses) are major risks of treatment. The target enzyme of warfarin, vitamin K epoxide reductase complex 1 (VKORC1), is encoded by the highly polymorphic VKORC1 gene and gene polymorphisms contributes to approximately 30% of the variability in dose. In this study, we used polymerase chain reaction (PCR) and direct DNA sequencing to genotype the two most clinically important variants (rs9923231 and rs7294) of the VKORC1 gene among Emiratis. We genotyped 117 healthy Emirati nationals and found that the frequencies of the rs9923231 genotypes GG, GA and AA are 0.256, 0.496 and 0.248, respectively. The frequency of the G allele for this single nucleotide polymorphism (SNP) is 0.504 while the frequency of the A allele is 0.496. However, the frequencies of the rs7294 GG, GA and AA genotypes are 0.462, 0.393 and 0.145, respectively. The alleles frequencies for this SNP were 0.660 for the G allele and 0.340 for the A allele. Genotypes and allele frequencies of the two studied SNPs were found to be different between the Emirati population studied and Indian and Chinese populations; however, they were similar to the frequencies found in Caucasians and other regional populations, such as the Saudis, Turkish and Iranians. These findings are potentially important for determining the starting warfarin dose for Emirati patients requiring anticoagulant treatment.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed244    
    Printed21    
    Emailed0    
    PDF Downloaded41    
    Comments [Add]    
    Cited by others 1    

Recommend this journal